There is growing evidence that the complex clinical manifestations of lysosomal storage diseases (LSDs) are not fully explained by the engorgement of the endosomal-autophagic-lysosomal system. In this review, we explore current knowledge of common pathogenetic mechanisms responsible for the early onset of tissue abnormalities of two LSDs, Mucopolysaccharidosis type II (MPSII) and Niemann-Pick type C (NPC) diseases. In particular, perturbations of the homeostasis of glycosaminoglycans (GAGs) and cholesterol (Chol) in MPSII and NPC diseases, respectively, affect key biological processes, including morphogen signaling. Both GAGs and Chol finely regulate the release, reception and tissue distribution of Shh. Hence, not surprisingly, developmental processes depending on correct Shh signaling have been found altered in both diseases. Besides abnormal signaling, exaggerated activation of microglia and impairment of autophagy and mitophagy occur in both diseases, largely before the appearance of typical pathological signs.
Introduction
For many years the engorgement of lysosomes with undigested macromolecules and the subsequent functional cell impairment have been accepted as primary causes for the pathogenesis of many lysosomal storage diseases (LSDs). However, the lysosomal-dependent cellular engulfment of undigested material has never fully explained the variety of phenotypes displayed by different LSDs. In recent decades, a more nuanced approach has disclosed the important roles of altered autophagy and stimulation of inflammatory responses in the pathology of LSDs.
The interplay between the accumulation/mislocalization of substrates and alteration of signaling pathways is also gaining attention in the context of LSDs (1) . Glycosaminoglycan (GAG) fragments accumulating in Mucopolysaccharidoses are typically attached to proteoglycans, which acting as co-receptors, finely regulate the activity of major signaling pathways (2) . Gangliosides, sphingolipids and cholesterol accumulating in Lipidoses assemble cell surface microdomains, including caveolae (3), lipid rafts (4) and glycosphingolipids-enriched microdomains (5) , which serve as platforms for signal transduction. Therefore, aberrant signaling cascades contribute to and activate both Shh and Smoothened (Smo). Also, lysosomal Chol, as well as GAG engorgement, may perturb the autophagic flux, leading to cell damage (Fig.1 ).
The enrichment of cholesterol in lipid rafts, as a means to set the necessary microenvironment for signal transduction, is being re-framed in light of the discovery of a highaffinity cholesterol-binding motif in the intracellular juxtamembrane domain of receptor proteins (10) . The precise arrangement of this motif, which is called "cholesterol recognition aminoacid consensus (CRAC) and its mirror motif, CARC, in the inner and outer leaflet of the plasma membrane, respectively, suggests a direct role of cholesterol in the activation processes.
We here overview current findings supporting a novel concept, whereby alterations of different key biological processes, including morphogenetic pathways (see Table 1 ), autophagic flux and mitophagy, may account for the onset of early LSD-related tissue manifestations. To this purpose, we examine two distinct LSD diseases: Mucopolysaccharidosis type II (MPSII; Hunter syndrome/disease) and Niemann-Pick C 1 and 2 (NPC1,2), which despite affecting the GAG catabolism and intracellular trafficking of endocytosed cholesterol, respectively, appear to share common related pathogenic mechanisms. disease, the severe heart disease leading to early death is likely to be due to heparan sulfatemediated changes in cell signaling.
Perhaps, similar alterations of cell signaling caused by matrix-induced alterations of cell signaling contribute to other organ pathologies in Hunter syndrome. For instance, the severe diarrhea may not just be secondary to compression of the gut by splenomegaly. Shh and Indian hedgehog are essential for smooth muscle formation, while Shh is essential for gut innervation (33). Mesenchymal Wnt signaling in the developing gut seems to decrease as extracellular matrix formation increases (34). While only increased membranous cytoplasmic bodies have been observed in an ultrastructural study of the rectal wall in MPS II (35), decreases or alterations in the enteric nervous system or smooth muscle might be responsible for the diarrhea so frequently seen.
The Role of Autophagy in Hunter syndrome CNS and heart-related manifestations
There are several interesting studies implicating alterations of autophagy in the onset of neurodegeneration of MPS patients (36). These studies have mostly been performed in MPSs I, IIIA, IIIB, and VII. In these MPSs, accumulation of GAGs is strikingly accompanied by accumulation of gangliosides in the brain (37) as occurs in NPC1,2 (see below), while increased cholesterol (Chol), which is implicated in the failure of phagosome-lysosome fusion, is also detected in neuronal cell membranes of affected patients (38). Among major consequences of impaired phagosome-lysosome fusion is mitophagic impairment (digestion of dysfunctional mitochondria), which may lead to apoptosis of affected cells. The accumulation of damaged mitochondria has been shown in MPS with subsequent elevation of damaging reactive oxygen species (ROS) (39). The mitochondrial dysfunction in multiple LSDs and its consequences for neurodegeneration have been well reviewed by Saffari, et al (40) . Altered mitochondrial function also seems important in NPC1,2 (see below). However, it is the balance of apoptosis (which is not a major process to occur in NPC1 [see below]) with non-apoptotic death, which is important since the latter stimulates the immune system while the former does not. The pattern recognition receptors (PRR) of the innate immune system recognize the extracellular GAGs by the addition of damage associated molecular partners (reviewed in 41), which are known to be involved in microglial activation and neuroinflammation (42). This microglial activation is responsible of the proinflammatory/neurodestructive pathway involving the so called A1 astrocytes (43), which has been found in multiple lysosomal storage disorders (44).
Autophagic processes are very important in early cardiac morphogenesis, as Atg5-deficient mice and atg5 zebrafish morphants exhibit abnormal heart structures, impaired heart looping and heart valve development (45). Moreover, defects in autophagy have been shown in the aging heart and enhancing autophagic processes delays cardiac aging. Many cardiac pathologies resulting in heart failure (ventricular dilation, cardiac hypertrophy and fibrosis) involve re-modelling, which is dependent on autophagy (46). The mitophagic pathway seems to have a homeostatic role in the heart (47) . Based on the emphasized role of autophagy in cardiac health, a number of autophagy-targeted drugs are being considered in heart diseases.
Although not yet studied in MPSs, altered autophagy may well contribute to the heart disease as well as to the neurodegeneration in MPSs.
Thus, while the precise role of mitophagic versus general autophagic defects remains unclear (see further discussion below for NPC1), the contribution of one or both to MPS pathology is clear. The role of activated microglia, with their recruitment of macrophages and other inflammatory cells (48) in neurodegeneration seems paramount. In this light, it is relevant that a drug targeted at inflammation, pentosan polysulfate, has shown promising results in the MPS VI rat model (49) . The addition of drugs targeted to inflammatory pathways, especially if they penetrate the BBB, to enzyme therapy would appear hopeful.
Niemann-Pick C Diseases
Niemann-Pick type C (NPC) disease is an autosomal recessive, neurodegenerative lysosomal storage disorder with variable clinical phenotypes (50) . The most common presentation of NPC disease is a child of either sex developing coordination problems, dysarthria, and hepatosplenomegaly during early school-age years. (55) . While NPC disease is most commonly associated with mutations in the NPC1 gene (56) , it can also be caused by mutations in a second gene, NPC2, which encodes a smaller, soluble lysosomal protein, which presents cholesterol to NPC1 (57, 58) .
The much greater rarity of NPC2 (5% of NPC cases) may be due to decreased fertility of male carriers since NPC2 is NPD is a milder mutant version of the NPC1 gene that apparently seemed different, with a large number of cases in an inbred population in Nova Scotia, until cholesterol storage was also identified in the disorder and mutations in NPC1 were found.
Although there has been some controversy as to whether cholesterol storage is causative for the pathology (versus sphingosine or gangliosides), it now seems clear that ganglioside accumulation is secondary, as in MPSs (59) . The success of the cholesterol sequestering hydroxypropyl-beta-cyclodextrins (HPβCD) in treating NPC1 also confirms the primary role of cholesterol storage. HPβCD has been previously used to modulate cholesterol trafficking across cell membrane (60) . Over a decade ago, an efficacious effect of HPβCD on slowing neurodegeneration in a mouse model of NPC1 was shown (61) . HPβCDs are substituted rings of 7 glucoses and do not cross the BBB. Since it seems counter-intuitive to treat a CNS disorder with a drug that does not cross the BBB, and because the effects are small when the drug is only started at the time of weaning, this drug appeared not particularly promising. Only when therapy was started at postnatal day 7, with higher doses, results were more dramatic. At this age the sealing properties of the BBB are not fully mature (62) and the drug is more slowly eliminated (6 hours instead of 3 hours; 63). This cholesterol-interacting compound is now in Phase I/II trials in humans, both using intravenous and intrathecal delivery. Intrathecal delivery has recently been found to significantly delay the pathological progress of NPC1 disease (64, 65) .
Altered development in Niemann-Pick C Diseases
Neurological symptoms, including ataxia, cognitive loss, seizures and dementia represent the most severe clinical manifestations of the NPC disease. The cerebellum is particularly affected, with Purkinje cells appearing more vulnerable than other cell types (66) .
Compared to other tissues/organs, the metabolism of cholesterol inside the brain is rather unique. Since cholesterol does not cross the blood brain barrier (BBB), which completely forms after birth (62), brain cholesterol comes exclusively from de novo synthesis.
During embryonic and early postnatal neurogenesis cholesterol synthesis occurs in both neurons and glial cells, while subsequently cholesterol produced by astrocytes is delivered to neurons via the LDL pathway and made available to the various cell compartments by NPC1/2-mediated cholesterol efflux from lysosomes (67) . This shift is expected to unmask the neuronal vulnerability to the deficiency of either proteins and to affect developmental processes. The morphogenesis of the cerebellar cortex is paradigmatic of such a condition, since it encompasses the 3 weeks after birth and is marked by intense neuronal/glial cell proliferation and migration, neurite outgrowth, synaptogenesis and myelin formation, which likely maximize the need for cholesterol (68) .
Our recent studies in mouse models have shown that Npc1 deficiency affects later steps of cerebellar morphogenesis, in spite of normal cerebellum development at earlier stages (69) . We found various subtle developmental defects, including the premature exit from cell cycle of granule neuron (GN) precursors (69) Defects of cerebellar morphogenesis of Npc1 mice are linked to altered Shh signaling (69, 11, 12) . This finding is consistent with the tight relationship between cholesterol metabolism and Shh signaling as indicated by the following evidence. First, active Shh protein is modified by covalent addition of cholesterol during its intracellular processing (73) . Shh cholesterol modification is relevant for generating temporal and spatial gradients of this protein (74) , which likely mediate pleiotropic signaling activities within the developing cerebellum. Starting from mouse embryonal day 17.5 (E17.5), Shh is continuously secreted by PC and diffuses upward to the external granule layer (EGL) and downward to the so-called prospective white matter (PWM, a secondary germinal zone of the postnatal cerebellum), driving the generation of excitatory (GNs) and inhibitory interneurons, respectively. Fate mapping studies have shown that neural stem cell-like "astroglial cells" in the PWM generate these late-born interneurons, called basket and stellate cells that provide GABAergic input to the PCs. In response to Shh, a niche of progenitors residing in the PWM, also generates astrocytes (75) .
Second, genes encoding Ptc1 and Npc1 share sequence homology, mostly confined to their 12 transmembrane segments, including the sterol-sensing domain, a motif implicated in lipid intracellular trafficking (53) . Accordingly, it was reported that Ptc1 contributes to cholesterol efflux from the cell (76) . Third, a selected group of compounds inhibits both Shh signaling, regulated by Ptc1, and late endosomal lipid sorting, regulated by NPC1, suggesting that Ptch1 regulates Smo activity through a common late endosomal sorting pathway also used by NPC1 protein (77) . Fourth, the morphology/function of primary cilium, a crucial center of Shh signaling transduction, depends on lipid composition (78) . Of note, two studies have recently reported that the primary cilium length is significantly reduced in NPC patient fibroblasts and brain sections of Npc1-deficient mice (11, 12) .
A recent study further emphasizes the relevance of cholesterol for Shh signaling, identifying Smo as the second cholesterol-modified protein and showing that the cholesterol modification of Smo is essential for Shh signal transduction and proper embryonic development (79) . The homozygous mutation of the aspartate aminoacid residues, to which the cholesterol moiety is bound, is embryonic lethal due to severe cardiac defects.
The phenotype of a mouse model in which a mutation in the NAD(P) dependent Importantly, these in vivo studies confirmed that there was decreased autophagosome activity due to the lack of fusion with lysosomes in cerebellum and liver (86) . These authors pointed out that an excess of cyclodextrin could be harmful by preventing the key role of normal autophagy in cellular homeostasis (86) . The Lieberman group came to agreement with these conclusions when they studied the effects of the tau knockout with Npc1 deficiency (87) HPβCD.
An alternative mechanism of inhibition of autophagosome-lysosome fusion was proposed to be due to sphingosine accumulation (90). Evidence was provided for a decreased level of VEGF a protein well known in lymphatic and blood vasculature formation, with subsequent depression of sphingosine kinase activity. A mechanism for this surprising decrease of VEGF was not given but cross-breeding with a VEGF over-expressing transgenic line led to a modest increase in survivial rates of the Npc1 null mice (90). Necroptosis, a form of cell death involving RIP1 and RIP3 kinases has also been implicated in the death of NPC1 neurons and its inhibition with a RIP1 antagonist extended survival in Npc1 model mice (91) .
A primary initiator of autophagic irregularities in NPC1 may be the accumulation of altered mitochondria. The mitochondrial role in autophagy is well recognized as they supply the membranes for the formation of the autophagosomes during starvation (92) . As studied in neurons, there is increased mitochondrial membrane cholesterol in NPC1 mutant cells and brains reduces ROS, extends life expectancy in the Npc1 model mice (99) . Since caveolin 1 has been shown to have a role in mediating autophagy and preventing ROS activity (at least in endothelial cells; 103), the elevation of caveolin 1 seen in NPC1 (104) may be a secondary cellular response to ROS-dependent stress. Defective mitochondria, with increased levels of oxidative stress markers and decreased survival (shortened chronological life span) were also found in the yeast model of NPC1 (105) . These defects seemed to be secondary to elevated sphingolipid levels.
Alterations in in lysosomal calcium levels due to sphingosine accumulation have been previously shown by Lloyd-Evans, et al. (106) . A defect in calcium release was found to be a more general defect in lysosomal storage diseases, including NPC1, but lysosomal calcium levels were found to be normal (107) . A third group found low lysosomal calcium levels which could be raised, and cholesterol storage corrected, by stimulation of the adenosine receptor A 2A (108) .
Thus, although there is a disagreement about whether lysosomal calcium is decreased, there is agreement that calcium release is abnormal, whether or not it is due to initially low levels of calcium.
There are many other proteins involved in mitophagy which could be altered in NPC1. These include the outer mito membrane receptor Atg32, its partner Atg11, and CK2 kinase need to phosphorylate it (reviewed in 109). The PINK1-PRKN/PRK2 pathway, well studied in Parkinson's disease, senses mito depolarization, which leads to outer mito membrane ubiquitination and mitophagy (109) .
In addition to "classical" mitophagy of defective mitochondria in the autophagosome, there is some evidence for an alternative route for removing them involving mitochondria-derived vesicles. These incorporate oxidized mitochondrial fragments and are delivered directly to the lysosome (110) . Alterations of this pathway in LSDs has not been explored yet to our knowledge.
A further pathway of interest involves the small GTPase Rab7, which influences endosome motility and is also implicated in mitochondrial-lysosome contact (111) . Its over-expression corrected the abnormalities of cholesterol storage in cultured NPC1 cells (112) .
It is clear that defective mitophagy allows these abnormal mitochondria to persist when they should be removed (86) and the defect may be due to increased cholesterol in membranes as outlined above for MPSs pathogenesis. However, mitochondrial alterations may themselves cause altered autophagy. Mitochondria associate with a special portion of the endoplasmic reticulum named mitochondria-associated ER membranes (MAM). This location is the major site of phospholipid, cholesterol ester, and fatty acid metabolism (113) .
Experimental evidence has suggested that MAMs-related abnormalities, especially as indicated by the differences between ApoE4 and ApoE3 effects are the primary problem in both sporadic late-onset Alzheimers disease (SLAD) and genetic Alzheimers disease (presenilin and amyloid precursor protein mutations) (113) . NPC1 has been called "juvenile Alzheimers". The similarity between NPC and Alzheimer is based on the presence of neurofibrallary tangles, influence of APOE-4 genotype on severity, and the association of variants in the human NPC1 gene with the onset of sporadic, late onset Alzheimers (114, 115) . Thus, it might be anticipated that similar alterations in lipid and phospholipid synthesis, affecting phagosome-lysosome fusion and leading to the same pro-inflammatory events described above in MPSs, may be present in NPC1.
Altered mitochondrial respiration may also be important for impaired autophagy. As studied in T cells, markedly reduced mitochondrial respiration is associated with decreased autophagosome-lysosome fusion with subsequently increased inflammatory responses (116).
Thus, altered mitochondria have multiple roles in autophagy.
Another possibly anomalous relationship of NPC1 to autophagy concerns the target of rapamycin, TOR. The TOR kinase is the major inhibitory signal of autophagy in the presence of abundant nutrients. NPC1 is part of a signaling complex that activates TOR in the presence of cholesterol (117). While free cholesterol is abundant in NPC1 lysosomes, in normal cells, NPC1 binds to a TOR regulating protein, SLC389, to inhibit TOR. Thus, autophagy would not be expected to be decreased. Again, in vivo, autophagy is increased but abnormal. These studies have been performed in cultured cells under oxidative stress i.e.
at 20% oxygen instead of the physiological 5% level. Also, it is possible that the very excessive levels of free cholesterol present in NPC1 cells would overcome the absent/decreased TOR signaling due to the down-regulation of autophagy. Finally, it must be remembered that autophagy is an ancient process and involves redundancy with over 100 proteins involved. Combined loss of function of different autophagic-related proteins is likely to be needed to evaluate the relation between autophagic defects and NPC disease. In addition, it has been previously shown that the major process of cell death in a Npc1 mouse model does not involve apoptosis since over-expression of Bcl2, an inhibitor of apoptosis, did not change the rate of Purkinje cell death or the progress of the disease (118).
The subsequent stimulus to inflammation, primarily mediated by microglia (51) follows the pathway described above for MPSII with the additional wrinkle that Purkinje cell expression of VEGF, as mentioned above, seems to have a protective effect (119). The neuroinflammatory pathway has also been specifically studied in the olfactory bulb of NPC1 model mice. Seo et al (120) explored the mechanism of activation of the neuropathic microglial response in the olfactory system, finding that the cysteine endopeptidase, Ctss, is involved in the activation of its target, Cx3cl1 (also known as neurotactin), resulting in p38 mitogen-activated protein kinase signaling (120) . The nasal delivery of antibody to Cx3cl1 was shown to decrease the number of damaged OB neurons and slightly enhance olfaction (120) .
Given the abundant evidence for neuroinflammation, it is also important to note that drugs primarily directed against inflammation, such as vitamin E (121), curcumin (122) , and non-steroidal anti-inflammatory drugs (123) , have only had modest effects in alleviating neurodegeneration. In contrast, the group studying neuroinflammation in the olfactory bulb found that a 4 weeks treatment with cyclosporine A markedly reduced neuroinflammation in the olfactory epithelium (124) .
Conclusions
Since the discovery of the pathological hallmarks, clinical manifestations of MPSII and NPC1,2 have been related to the accumulation of glycosaminoglycans and unesterified cholesterol, respectively. More recently this perspective has been enlarged thanks to a 
